TIEU VY NGUYEN, M.D.
Ophthalmology Physician · SUGAR LAND, TX
Individual Active NPI 1699154799
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 731 | 27,794 | $11,906,789 | $3,628,226 | $2,870,283 |
| 2023 | 693 | 19,867 | $11,056,376 | $3,530,607 | $2,788,668 |
| 2022 | 697 | 9,643 | $6,106,158 | $3,142,933 | $2,487,995 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 15,960 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 2,325 | $147 | $117 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,976 | $327 | $260 |
| 92134 | Imaging of retina | 1,751 | $42 | $31 |
| J0178 | Injection, aflibercept, 1 mg | 1,394 | $818 | $651 |
| 67028 | Injection of drug into eye | 1,343 | $136 | $105 |
| 92014 | Established patient complete exam of visual system | 927 | $129 | $96 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 837 | $232 | $184 |
| J2778 | Injection, ranibizumab, 0.1 mg | 539 | $151 | $120 |
| 92250 | Photography of the retina | 145 | $38 | $29 |
| J3590 | Unclassified biologics | 89 | $2,631 | $2,090 |
| 92004 | New patient complete exam of visual system | 83 | $150 | $98 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | S8084 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | S8480 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1700801677
- NPI 1023684727
- NPI 1497908883
- NPI 1578547881
- NPI 1417976523
- NPI 1689792053
- NPI 1326482902
- NPI 1245199785
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.